April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Opposes Trump and Senate Republicans' Big Bad Bill Ahead of the Vote
- Wyden Blasts Budget Fakery as Republicans Go Nuclear
- Wyden Statement on Latest Parliamentarian Guidance
- Wyden Statement on New CBO Numbers Showing More than $930 Billion in Medicaid Cuts In New Senate Draft
- Wyden Blasts Republican “Death Sentence” for American Clean Energy, Warns of Imminent Utility Bill Hike